惠民保与基本医保药品保障衔接水平分析方法及实证研究  被引量:3

Analysis Method and Empirical Study on the Cohesion Level of Inclusive Commercial Health Insurance and Basic Medical Insurance Drug Security

在线阅读下载全文

作  者:姜骁桐 郭珉江[1] 刘阳 李亚子[1] JIANG Xiao-tong;GUO Min-jiang;LIU Yang(Institute of Medical Information,Chinese Academy of Medical Sciences,Beijing,100020,China;不详)

机构地区:[1]中国医学科学院医学信息研究所健康与医疗保障研究中心,北京100020

出  处:《中国卫生经济》2023年第6期30-33,45,共5页Chinese Health Economics

摘  要:目的:为评估惠民型商业补充医疗保险与基本医保药品保障衔接水平提供分析框架,以期为惠民型商业补充医疗保险产品药品待遇政策的评估与设计提供参考。方法:借鉴经济合作与发展组织对商业健康保险和医疗保障体系衔接方式的定义,将其应用到药品保障领域的衔接水平分析,并以“沪惠保”为例进行实证分析。结果:基于惠民型商业补充医疗保险和基本医保在药品保障范围、渠道和待遇方面的差异,将两者衔接方式分为3种类型,分别为补充型、增强型和重叠型。结论:惠民型商业补充医疗保险药品待遇政策的设计与评估应兼顾考虑国家基本医保药品目录、城市间待遇水平差异、产品筹资与管理水平。在具体药品的遴选上,可以借助国家医保谈判工作的经验。Objective:To provide an analytical framework for assessing the convergence level of drug reimbursement benefits between inclusive commercial health insurance(ICHI)and basic medical insurance(BMI).Methods:Based on Organization for Economic Co-operation and Development's definition of the linkage between commercial health insurance and medical security system,it is applied to the analysis of the level of linkage in the field of drug reimbursement,taking"Hu Huibao"as an example for empirical analysis.Results:The research divides the connection between the ICHI and BMI into supplementary,complementary and overlapping types based on the differences of ICHI and BMI in coverage,path and salary.Conclusion:The design and appraisal of the drug security policy of ICHI should consider the BMI drug catalogue,the difference in treatment level between cities and the level of product financing and management.The drug selection could learn from the experiences of national medical insurance negotiation.

关 键 词:惠民型商业补充医疗保险 基本医疗保险 药品保障 衔接水平 

分 类 号:R1-9[医药卫生—公共卫生与预防医学] F840.613[经济管理—保险]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象